Teradyne's AI Dependency Deepens, But Proof Points Remain Pending

What happened

Teradyne's AI-driven test business now accounts for nearly 70% of revenue, bolstering the narrative of a structural shift toward AI infrastructure testing. However, the company's latest filings only explicitly forecast AI dominance for the next quarter, leaving the durability of this mix unconfirmed. The investment thesis hinges on two critical proofs: merchant GPU systems entering production in Q2'26 and filings extending the 'bulk of revenue' language into the second half. While new platforms like MultiLane Test Products and TestInsight signal expansion into data-center test, they have yet to contribute material revenue. At a P/E of 61.9, the stock prices in sustained AI momentum that remains unvalidated beyond the immediate term.

Implication

The current valuation embeds an expectation that AI-related demand will remain dominant for 12-24 months, but the most recent filing only guarantees this for one quarter. Investors should monitor the Q2'26 earnings call for confirmation that merchant GPU systems have shipped and that management extends the 'bulk of revenue' language into 2H'26. Until these proofs materialize, the stock is vulnerable to multiple compression if AI demand normalizes or product test adjacencies fail to scale. The attractive entry point of $280 per the DeepValue report provides a margin of safety if the thesis breaks. Given the crowded AI narrative and limited visibility, patience is warranted.

Thesis delta

The Zacks article reinforces the bullish AI narrative, but the DeepValue report's WAIT rating highlights that the stock already prices in this momentum. No new evidence has emerged to shift the thesis from 'wait for confirmation' to 'buy'. The core risk—that AI dominance is only explicitly forecast for the current quarter—remains unchanged.